Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440

Showing 26-50 of 440 citing articles:

ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection
Tianhao Duan, Changsheng Xing, Junjun Chu, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 4, pp. 628-644
Closed Access | Times Cited: 19
Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 19
The gasdermin family: emerging therapeutic targets in diseases
Cheng‐long Zhu, Sheng Xu, Ruoyu Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung
Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 15
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Inflammasome Activation by RNA Respiratory Viruses: Mechanisms, Viral Manipulation, and Therapeutic Insights
Tamara Silva Rodrigues, Dario S. Zamboni
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access | Times Cited: 1
An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
Katherine C. Barnett, Yuying Xie, Takanori Asakura, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 2, pp. 243-259.e6
Open Access | Times Cited: 50
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 47
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
Santosh Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1391-1391
Open Access | Times Cited: 46
Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients
Alessandra Giannella, Silvia Riccetti, Alessandro Sinigaglia, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization
Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111214-111214
Open Access | Times Cited: 41
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
Arinna Bertoni, Federica Penco, Hilaria Mollica, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 4, pp. 796-805
Open Access | Times Cited: 38
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond
Anthony R. Sciaudone, Heather A. Corkrey, Fiachra Humphries, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1272-1289
Open Access | Times Cited: 38
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
Shen Lu, Yanrong Li, Zhaojun Qian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Host Recovery from Respiratory Viral Infection
Xiaoqin Wei, Harish Narasimhan, Bibo Zhu, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 277-300
Open Access | Times Cited: 34
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release
Larisa I. Labzin, Keng Yih Chew, Kathrin Eschke, et al.
Science Signaling (2023) Vol. 16, Iss. 782
Closed Access | Times Cited: 31
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
Yang Li, Qianzhou Jiang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome
Brian V. Tsu, Rimjhim Agarwal, Nandan S. Gokhale, et al.
PLoS Biology (2023) Vol. 21, Iss. 6, pp. e3002144-e3002144
Open Access | Times Cited: 29
Pyruvate dehydrogenase kinase supports macrophage NLRP3 inflammasome activation during acute inflammation
Allison K. Meyers, Zhan Wang, Wenzheng Han, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111941-111941
Open Access | Times Cited: 22
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 22

Scroll to top